Immune therapy for infectious diseases at the dawn of the 21st century: The past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers

Current Pharmaceutical Design

Volumn 9, Issue 12, 2003, Pages 945-968

  Buchwald, U K ^a   Pirofski, L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antibody; Antibody based therapy; Antimicrobial resistance; Cytokines; Emerging infectious diseases; Host defense; Immune therapy; Immunocompromised host; Serum therapy; Therapeutic vaccination

Indexed keywords

ALPHA INTERFERON; ANTIBODY; ANTIINFECTIVE AGENT; BIOLOGICAL RESPONSE MODIFIER; BOTULINUM ANTISERUM; CYTOKINE; CYTOKINE ANTIBODY; CYTOMEGALOVIRUS ANTIBODY; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B VACCINE; HERPES SIMPLEX VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; LEISHMANIA VACCINE; MONOCLONAL ANTIBODY; PALIVIZUMAB; POLYCLONAL ANTIBODY; POLYSACCHARIDE; RECOMBINANT COLONY STIMULATING FACTOR; RIBAVIRIN; SYNGAM; THYMOSIN ALPHA1; UNINDEXED DRUG; VIRUS ANTIBODY;

ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CAPILLARY LEAK SYNDROME; DISEASE EXACERBATION; DRUG HALF LIFE; DRUG MEGADOSE; EPIDEMIC; ERYTHEMA NODOSUM LEPROSUM; FEVER; FLU LIKE SYNDROME; GRANULOCYTE; HEADACHE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOTHERAPY; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; MYALGIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; SERUM SICKNESS; SKIN LEISHMANIASIS;

ANIMALS; ANTIBODIES; BIOLOGICAL RESPONSE MODIFIERS; COMMUNICABLE DISEASES; FORECASTING; HUMANS; IMMUNOTHERAPY; VACCINATION;

EID: 0037259397     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033455189     Document Type: Review

References (298)

1. Finland M. Rev Infect Dis 1983; 5 (Suppl 1): S2-S8.
2. Conn HW, Conn HJ. In: Conn HW, Conn HJ Eds, Bacteriology 4th edition. Baltimore, The Williams and Wilkins Co. 1929; pp 24-38.
3. Baldry PE Ed, The Battle against Bacteria: A History of the Development of Antibacterial Drugs for the General Reader. Cambridge, Cambridge University Press 1965.
4. Behring E, Kitasato S. Dtsch med Wochenschr 1890; 49: 1113-1114.
5. Gronski P, Seiler FR, Schwick HG. Mol Immunol 1991; 28: 1321-1332.
6. Casadevall A, Pirofski LA. Infect Immun 1999; 67: 3703-3713.
7. Osler W Ed, Modern Medicine It's Theory and Practice. Philadelphia and New York, Lea Brothers & Co. 1907; 2.
8. Krause RM. Vaccine 1999; 17: S64-S67.
9. Park WH, Schroder MC. J Am Pub Health Assoc 1932; 22: 7-19.
10. Fothergill LD. Med Clin North Am 1936; 19: 1409-1438.
11. Morse NC. In: Morse NC Ed, Emergencies of a General Practice Medicine. St Louis, CV Mosby Co. 1918; pp 227-232.
12. Spaeth R. Arch Intern Med 1941; 68: 1133-1160.
13. Blake FG, Trask JD. NY State J Med 1925; 25: 1093-1099.
14. Wadsworth AB. Am J Public Health 1929; 19: 1287-1302.
15. Wesselhoeft C. Med Clin North Am 1936, 19: 1389-1407.
16. Stevens DL. Clin Infect Dis 1998; 26: 639-641.
17. Heffron R. Ed, Pneumonia with Special Reference to Pneumococcus Lobar Pneumonia. New York, The Commonwealth Found. 1939; pp 832-842.
18. Park WH, Williams AW, Krumwiede C. Eds, Pathogenic Microorganisms 6th edition. New York and Philadelphia, Lea & Febiger 1917.
19. Cecil RL. Bull NY Acad Med 1939; 15: 104-115.
20. Klemperer G, Klemperer F. Berlin Klin Wochenschr 1891; 28: 833-835.
21. Casadevall A, Scharff MD. Antimicrob Agents Chemother 1994; 38: 1695-1702.
22. Henrichsen J. Am J Med 1999; 107: 50S-54S.
23. Bullowa JG. JAMA 1935; 105: 1512-1518.
24. Pirofski LA. Trends Microbiol 2001; 9: 445-451.
25. Cooper G, Rosenstein C, Walter A, Peizer, L. J Exp Med 1932; 55: 531-554.
26. Cecil RL. JAMA 1937; 108: 589-692.
27. Dowling HF, Abernethy TJ. Am J Med Sci 1940; 199: 55-62.
28. Felton LD. JAMA 1930; 94: 1893-1896.
29. Tilghman RC, Finland M. J Immunol 1936; 31: 239-255.
30. Horsfall FL, Goodner K, MacLeod, CM, Harris AH. JAMA 108: 1483-1487.
31. Goodner K, Horsfall FL, Jr, Dubos RJ. J Immunol 1937; 33: 279-285.
32. Barnes LA, Kramer SD. Am J Pub Health 1936; 26: 51-56.
33. Finland M. Med Clin North Am 1939; 23: 1205-1219.
34. Felton LD. J Infect Dis 1928; 43: 531-542.
35. Taborda CP, Casadevall A. J Immunol 2001; 166: 2100-2107.
36. Flexner S. J Exp Med 1913; 17: 553-576.
37. McGrae T. In: McGrae T Ed, Osler's Modern Medicine 3rd edition. Philadelphia and New York, Lea & Febiger 1925; pp 583-587.
38. Krause RM, Dimmock NJ, Morens DM. J Infect Dis 1997; 176: 549-559.
39. Walsh G. JAMA 1938; 110: 1894-1896.
40. Alexander HE. Am J Dis Child 1943; 66: 160-171.
41. Casadevall A, Scharff MD. Clin Infect Dis 1995; 21: 150-161.
42. Park WH. N Y State J Med 1933; 33: 91-94.
43. Lewis JM, Barenberg LH. NY State J Med 1933; 33: 97-99.
44. Gallagher JR. Am J Public Health 1935; 25: 595-598.
45. Sawyer LA. Antiviral Research 2000; 47: 57-77.
46. Kelly J. Microb Infect 2000; 2: 1383-1392.
47. Rascoff H, Nussbaum S. Am J Dis Child 1940; 60: 552-561.
48. Tunnicliff R. J Infect Dis 1939; 64: 59-65.
49. Fisher MW. Antibiot Chemother 1957; 7: 315-321.
50. Osgood EE, Powell HM. Proc Soc Exp Biol Med 1938; 39: 37-40.
51. Casadevall A. Clin Infect Dis 1996; 23: 790-794.
52. Louie M, Louie L, Simor AE. CMAJ 2000; 8: 301-309.
53. Casadevall A, Pirofksi L. Infect Immun 1999; 67: 3703-3713.
54. Casadevall A, Pirofski L. Ann of Med 2002; 34: 1-3.
55. Pirofski L, Casadevall A. Clin Microbiol Rev 1998; 11: 1-26.
56. Lederberg J, Shope R, Oaks SC. Report: Institute of Medicine "Emerging Infections: Microbial Threats to Health in the United States". Washington, DC, National Academy Press 1992; p 294.
57. Krause RM. In: Krause RM Ed, Emerging Infections. New York, Academic Press 1998; pp 1-22.
58. Morse SS. Emerg Infect Dis 1995; 1: 7-15.
59. Casadevall A, Pirofski LA. J Infect Dis 2001; 184: 337-344.
60. Mortimer SA. In: Plotkin SA, Moritmer EA Eds, Vaccines. Philadelphia, Saunders 1994; 91-135.
61. Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling, PB, et al. JAMA 1999; 285: 1059-1070.
62. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, et al. N Engl J Med 2001; 14: 1807-1814.
63. Engelthaler DM, Mosley DG, Cheek JE, Levy CE, Komatsu KK, Ettestad P, et al. Emerg Infect Dis 1999; 5: 87-94.
64. Levy SB. In: Jungkind DL Ed, Antimicrobial Resistance: A Crisis in Health Care. New York, Plenum Press 1995; pp 1-23.
65. Shlaes DM, Binczewski B, Rice LB. Clin Infect Dis 1993; 17 (Suppl 2): S527-S536.
66. Janoff EN, Rubins JB. Microb Drug Resist 1997; 3: 215-232.
67. Gillespie SH. Int J Antimicrob Agents 2001; 17: 171-176.
68. Davidson R, Cavalcanti R, Brunton JL, Bast DJ, De Azavedo JCS, Kibsey P, et al. New Engl J Med 2002; 346: 747-750.
69. Gold HS, Moellering RC. New Engl J Med 1996; 335: 1445-1453.
70. De Pauw B. Clin Microbiol Infect 2000; 6 (Suppl 2): 23-28.
71. Flahault A, Valleron AJ. Lancet 1990; 336: 1197-1198.
72. Moore DAJ, Edwards M, Escombe R, Agranoff D, Bailey JW, Squire SB, et al. Emerg Infect Dis 2002; 8: 74-76.
73. Kirkland TN, Fierer J. Emerg Infect Dis 1996; 3: 192-199.
74. Markina SS, Maksimova NM, Bogatyreva EY, Monisov AA. J Infect Dis 2000; 181 (Suppl 1): S27-S34.
75. Epstein P. Microbes Infect 2001; 3: 747-754.
76. Murphy FA, Peters CJ. In: Emerging Infections Krause RM, Ed, Academic Press: New York 1998; pp 375-410.
77. Field H, Young P, Yob JM, Mills J, Hall L, Mackenzie J. Microbes Infect 2001; 3: 307-314.
78. Aguzzi A, Glatzel M, Montrasio F, Prinz M, Heppner FL. Nature Rev 2001; 2: 745-749.
79. Casadevall A. Nat Biotechnol 2002; 20: 114.
80. Gold BS, Wingert WA. South Med J 1994; 67: 579-589.
81. Pennington JE. Trans Am Clin Clim Assoc 1987; 99: 126-135.
82. Fischer GW. Infect Dis Clin North Am 1992; 6: 97-116.
83. US Code of Federal Regulations Title 21: part 640104.
84. Lamari F, Karamanos NK, Papadopoulou-Alataki E, Kanakoudi-Tsakalidou F, Dimitracopoulos G, Anastassiou ED. J Pharm Biomed Anal 2000; 22: 1029-1036.
85. Alejandria MM, Lansang MA, Dans LF, Mantaring JBV. The Cochrane Library 2001; 4: CD 001090.
86. Kress HG, Scheideweg C, Schmidt H, Silber R. Crit Care Med 1999; 27: 1281-1287.
87. Gelfand EW. J Allerg Clin Immunol 2001; 108 (Suppl 4): S111-S116.
88. Kazatchkine MD, Kaveri SV. New Engl J Med 2001; 345: 747-755.
89. Koehler G, Milstein C. Nature 1975; 256: 495-497.
90. Breedveld FC. Lancet 2000; 355: 735-740.
91. Vaughan TJ, Osbourn JK, Tempest PR. Nat Biotechnol 1998; 16: 535-539.
92. Kalinke U, Krebber A, Krebber C, Bucher E, Pluckthun A, Zinkernagel RM, et al. Eur J Immunol 2000; 26: 2801-2806.
93. Ramisse F, Binder P, Szatanik M, Alonso J-M. J Infect Dis 1996; 173: 1123-1128.
94. The IMPACT-RSV Study Group Pediatrics 1998; 102: 531-537.
95. Boeckh M, Berrey MM, Bowden RA, Crawford S W, Balsley J, Corey L. J Infect Dis 2001; 184: 350-354.
96. Armbruster C, Stiegler G, Veelar BA, Jaeger W, Michael NL, Vetter N, et al. AIDS 2002; 16: 227-233.
97. Jacobson JM, Lowy I, Fletcher CV, O'Neill TJ, Tran DNH, Ketas TJ, et al. J Infect Dis 2000; 182: 326-329.
98. Boeckh M, Bowden RA, Storer B, Chao NJ, Spielberger R, Tierney DK, et al. Biol Blood Marrow Transplant 2001; 7: 343-351.
99. Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, et al. Antimicrob Agents Chemother 1998; 42: 1437-1446.
100. Matthews R, Burnie J. Curr Opin Invest Drugs 2001; 2: 472-476.
101. Keller MA, Stiehm ER. Clin Microbiol Reviews 2000; 13: 602-614.
102. Hammarstroem L, Gardulf A, Hammarstroem V, Janson H, Lindberg K, Smith CIE. Immunol Rev 1994; 139: 43-70.
103. Skerrett SJ. Sem Resp Infect 2001; 16: 67-75.
104. Spector SA, Gelber RD, McGrath MS, Wara D, Barzilai A, Abrams E, et al. New Engl J Med 1994; 331: 1181-1187.
105. Mofenson LM, Moye J Jr, Korelitz J, Bethel J, Hirschhorn R, Nugent R. Pediatr Infect Dis 1994; 13: 477-484.
106. Olopoenia L, Young M, White D, Barnes S, Rahbar F, Fomufod A. J Natl Med Assoc 1997; 89: 543-547.
107. Sacher RA. J Allergy Clin Immunol 2001; 108 (Suppl 4): S139-S146.
108. Williams PE, Hague RA, Yap PL, Mok J, Brettle RP, Coutts NA, et al. J Hosp Infect 1988; 12 (Suppl D): 67-73.
109. Santhoshan M, Reid R, Ambrosino DN, Wolfe MC, Almeido-Hill J, Prochs C, et al. New Engl J Med 1987; 317: 923-929.
110. Abadi J, Friedman J, Mageed RA, Jefferis R, Rodriguez-Barradas MC, Pirofski L. J Infect Dis 1998; 178: 707-716.
111. Fleuridor R, Lyles RH, Pirofski L. J Infect Dis 1999; 180: 1526-1535.
112. Hougs L, Juul L, Svejgaard A, Barington T. Infect Immun 1999; 67: 2503-2514.
113. Chang Q, Abadi J, Alpert J, Pirofski L. J Infect Dis 2000; 181: 1313-1321.
114. Jenson HB, Pollock BH. Sem Perinatol 1998; 22: 50-63.
115. Ohlson A, Lacy JB. The Cochrane Library 2001; 4: CD001239.
116. Schedel I, Dreikhausen U, Nentwig B, Hockenschnieder M, Rauthmann D, Balikcioglu S, et al. Crit Care Medicine 1991; 10: 1104-1113.
117. Yuan R, Clynes R, Oh J, Ravetch JV, Scharff MD. J Exp Med 1998; 187: 641-648.
118. Yuan R, Casadevall A, Spira G, Scharff MD. J Immunol 1995; 154: 1810-1816.
119. Lendvai N, Qu XW, Hsueh W, Casadevall A. J Immunol 2000; 164: 4367-4374.
120. Savoy AL, Lupan DM, Manalo PB, Roberts JC, Schlageter AM, Weinhold LC, et al. Infect Immun, 1997; 65: 1800-1807.
121. Ott VL, Fong DC, Cambier JC. J Allergy Clin Immunol 2001; 108 (Suppl 4): S95-S98.
122. Simoes EA, Groothuis JR, Tristram DA, Allessi K, Lehr MV, Siber GR, et al. J Pediatr 1996; 133: 492-499.
123. Malley R, de Vincenzo J, Ramilo O, Dennehy PH, Meissner HC, Guber WC, et al. J Infect Dis 1998; 178: 1555-1561.
124. Parsonnet J. Curr Clin Top Infect Dis 1996; 16: 1-20.
125. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, et al. Clin Infect Dis 1999; 28: 800-807.
126. Schlievert PM. J Allerg Clin Immunol 2001; 108 (Suppl 4): S107-S110.
127. Patel SY, Kumararatne DS. Clin Exp Immunol 2001; 124: 169-171.
128. Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, et al. Gut 1997; 41: 366-370.
129. Bruss JB, Malley R, Halperin S, Dobson S, Dhalla M, Mciver J, et al. Ped Infect Dis J 1999; 18: 505-511.
130. Vierling, JM, Tepermann LW. Semin Liver Dis 2000; 20 (Suppl 1): 1-35.
131. Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, et al. Liver Transpl Surg 1999; 5: 491-496.
132. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, zum Buschenfelde K-HM, et al. Hepatology 1998; 27: 254-263.
133. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, et al. Hepatology 1992; 15: 757-766.
134. Valantine H, Luikart H, Doyle R, Theodore J, Hunt S, Oyer P, et al. Transplantation 2001; 10: 1647-1652.
135. Limaye AP, Corey L, Loelle DM, Davis CL, Boeckh M. Lancet 2000; 356: 645-649.
136. Nichols WG, Boeck M. J Clin Virol 2000; 16: 25-40.
137. Hasenkrug KJ, Brooks DM, Chesebro B. Proc Nat Acad Sci 1995; 92: 10492-10495.
138. Yuan R, Casadevall A, Oh J, Scharff MD. Proc Nat Acad Sci 1997; 94: 2483-2488.
139. Rivera J, Mukerjee J, Weiss LM, Casadevall A. J Immunol 2002; 168: 3419-3427.
140. Beenhouwer DO, Shapiro S, Feldmesser M, Casadevall A, Scharff MD. Infect Immun 2001; 69: 6445-6455.
141. Feldmesser M, Mednick A, Casadevall A. Infect Immun 2002; 70: 3: 1571-1580.
142. Paya CV. Transplant Infect Dis 1999; 1 (Suppl 1): 8-12.
143. Zeitlin L, Cone RA, Whaley KJ. Emerg Infect Dis 1999; 5: 54-64.
144. Kudoyarova-Zubavichene NM, Sergeyev NN, Chepurnov AA, Netesov SV. J Infect Dis 1999; 179 (Suppl 1): S218-S223.
145. Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M, et al. J Infect Dis 1999; 179 (Suppl 1): S18-S23.
146. Takada A, Watanabe S, Okazaki K, Kida H, Kawaoka Y. J Virol 2001; 75: 2324-2330.
147. Nussbaum G, Cleare W, Casadevall A, Scharff MD. J Exp Med 1997; 185: 685-694.
148. Nakouzi A, Valadon P, Nosanchuk J, Green N, Casadevall A. Infect Immun 2001; 69: 3398-3409.
149. Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, et al. Science 2000; 287: 1664-1666.
150. Maruyama T, Parren PWHI, Sanchez A, Rensink I, Rodriguez LL, Khan AS, et al. J Infect Dis 1999; 179 (Suppl 1): S235-S239.
151. Roehrig JT, Staudinger LA, Hunt AR, Mathews JH, Blair CD. Ann N Y Acad Sci 2001; 951: 286-297.
152. Enserink M. Science 2002; 295: 777.
153. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al. JAMA 2001; 285: 1059-1070.
154. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. JAMA 2001; 285: 2763-2773.
155. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, et al. JAMA 1999; 281: 1735-1745.
156. Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S, Altboum Z. Infect Immun 2002; 70: 544-550.
157. Diekema DJ, Pfaller MA, Jones RN, Doern GV, Kugler KC, Beach ML, et al. Int J Antimicrob Agents 2000; 13: 257-271.
158. Moellering R. Clin Infect Dis 2002; 34 (Suppl 1): S1-S3.
159. Yuste J, Gimenez MJ, Jado I, Fenoll A, Aguilar L, Casal J. J Antimicrob Chemother 2001; 48: 594-595.
160. Gordon MA, Casadevall A. Clin Infect Dis 1995; 21: 1477-1479.
161. Healey C, Sabharwal NK, Daub J, Davidson F, Yap P-L, Fleming KA, et al. Gastroenterology 1996; 110: 1120-1126.
162. Miller JL, Petteway SR, Lee DC. J Allerg Clin Immunol 2001; 108 (Suppl 4): S91-S94.
163. Nathanson N. Biologicals 1998; 26: 77-84.
164. Isaacs JD, Watts RA, Hazleman BL, Hale G, Keogan, MT, Cobbold SP, et al. Lancet 1992; 340: 748-752.
165. Clark M. Immunol Today 2000; 21: 397-402
166. Zeitlin L, Cone RA, Moench TR, Whaley KJ. Microbes Infect 2000; 2: 701-708.
167. Casadevall A. Trends Microbiol 1998; 6: 102-107.
168. Brixner DI, Bull SA. Am J Manag Care 1997; 3: 903-911.
169. Mullaney BP, Pallavicini MG, Marks JD. Infect Immun 2001; 6511-6514.
170. Van Spriel AB, Van Ojik HH, Van de Winkel JGJ. Immunol Today 2000; 21: 391-397.
171. Casadevall A, Pirofski LA. Clin Infect Dis 2001; 33: 1048-1056.
172. Burke DS. Vaccine 1993; 11: 883-894.
173. Cohen J. Science 1994; 264: 503-505.
174. Stanberry LR. Trends Microbiol 1995; 244-247.
175. Stanford JL. Trop Geogr Med 1994; 46: 93-107.
176. Mayrink W, Magalhaes PA, Michalick MS, DaCosta CA, De Lima Ade O, Melo MN, et al. Parassitologia 1992; 34: 159-165.
177. Convit J. Eth Med J 1974; 12: 187-195.
178. Convit J. Clin Dermatol 1996; 14: 479-487.
179. Convit J, Aranzazu N, Ulrich M, Zuniga M, Aragon ME, Alvarado J, et al. Int J Lepr 1983; 51: 531-539.
180. Genaro O, de Toledo VP, da Costa CA, Hermeto MV, Afonso LC, Mayrink W. Clin Dermatol 1996; 14: 503-512.
181. Badaro R, Lobo I, Nakatani M, Muinos A, Netto EM, Coler RN, et al. Braz J Infect Dis 2001; 5: 223-232.
182. Sharma P, Misra RS, Kar HK, Mukherjee A, Poricha D, Kaur H, et al. Lepr Rev 2000; 71: 179-192.
183. Talwar GP. Int Rev Immunol 1999; 18: 229-249.
184. Majumder V, Saha B, Hajra SK, Biswas SK, Saha K. Int J Lepr Other Mycobact Dis 2000; 68: 283-290.
185. De Bruyn G, Garner P. The Cochrane Library 2002; Issue 1: CD001166.
186. Straus SE, Corey L, Burke RL, Savarese B, Barnum G, Krause PR, et al. Lancet 1994; 343: 1460-1463.
187. Straus SE, Wald A, Kost RG, McKenzie R, Langenberg AGM, Hohman P, et al. J Infect Dis 1997; 176: 1129-1134.
188. Pivetti-Pezzi P, Accorinti M, Colabelli-Gisoldi RA, Pirraglia MP, Sirianni MC. Cornea 1999; 18: 47-51.
189. Michel M-L, Pol S, Brechot C, Tiollais P. Vaccine 2001; 2395-2399.
190. Vitiello A, Ishioka G, Grey HM, Rose R, Farness P, LaFond R, et al. J Clin Invest 1995; 95: 341-349.
191. Livingston BD, Crimi C, Grey H, Ishioka G, Chisari FV, Fikes J, et al. J Immunol 1997; 159: 1383-1392.
192. Heathcote J, McHutchinson J, Lee S, Tong M, Benner K, Minuk G, et al. Hepatology 1999; 30: 531-536.
193. Livingston BD, Alexander J, Crimi C, Oseroff C, Celis E, Daly K, et al. J Immunol 1999; 162: 3088-3095.
194. Pol S, Couillin I, Michel ML, Driss F, Nalpas B, Carnot F, et al. Acta Gastro-Enterol Belg 1998; 61: 228-233.
195. Couillin I, Pol S, Mancini M, Driss F, Brechot C, Tiollais P, et al. J Infect Dis 1999; 180: 15-26.
196. Soussan P, Pol S, Garreau F, Brechot C, Kremsdorf D. J Gen Virol 2001; 82: 367-371.
197. Boni C, Bertelotti A, Penna A, Cavalli A, Pilli M, Urbani S, et al. J Clin Invest 1998; 102: 968-975.
198. Gotch F, Hardy G, Imami N. Immunol Rev 1999; 170: 173-182.
199. Sukeepaisarncharoen W, Churdboonchart V, Kulpradist S, Isarangkura N, Ayudthya B, Rugpao S, et al. HIV Clin Trials 2001; 2: 391-398.
200. Turner JL, Kostman JR, Aquino A, Wright D, Szabo S, Bidwell R, et al. HIV Med 2001; 2: 68-77.
201. Kahn JO, Weng Cherng D, Mayer K, Murray H, Lagakos S. JAMA 2000; 284: 2193-2202.
202. Bunnell BA, Morgan RA. Clin Microbiol Rev 1998; 11: 42-56.
203. Deepe GS. Clin Microbiol Rev 1997; 10: 585-596.
204. Thitithanyanont A, Mendoza L, Chuansumrit A, Pracharktam R, Laothamatas J, Sathapatayavongs B, et al. Clin Infect Dis 1998; 27: 1394-1400.
205. Ridell SR, Greenberg PD. Annu Rev Immunol 1995; 13: 545-586.
206. Ridell SR, Greenberg PD. J Antimicrob Chemother 2000; 45: 35-43.
207. Berger DP, Homann D, Oldstone MBA. Virology 2000; 266: 257-263.
208. Fauci AS. Ann Intern Med 1987; 106: 421-433.
209. Clendening L In: Modern Methods of Treatment. St Louis, The Mosby Co. 1925; pp 187-190.
210. Huebel K, Dale DC, Engert A, Liles WC. J Infect Dis 2001; 183: 321-328.
211. Hartung T, Gaviria JM, Garrido SM, Root RK In: Holland SM Ed, Cytokine Therapeutics in Infectious Diseases. Philadelphia, Lippincott Williams and Wilkins 2001; pp 185-219.
212. Holland SM. In: Holland SM Ed, Cytokine Therapeutics in Infectious Diseases. Philadelphia, Lippincott Williams and Wilkins 2001; pp 221-250.
213. Miller KD, Kuruppu JC, Kovacs JA. In: Holland SM Ed, Cytokine Therapeutics in Infectious Diseases. Philadelphia, Lippincott Williams and Wilkins 2001; pp 15-44.
214. Opal SM, Wherry JC, Grint P. Clin Infect Dis 1998; 27: 1497-1507.
215. Romani L, Puccetti P, Bistoni F. Clin Microbiol Rev 1997; 10: 611-636.
216. Masihi KN. Int J Antimicrob Agents 2000; 14: 181-191.
217. Marriott JB, Muller G, Stirling D, Dalgleish AG. Expert Opin Biol Ther 2001; 1: 675-682.
218. Molloy RG, Mannick JA, Rodrick ML. Br J Surg 1993; 80: 289-297.
219. Dinarello CA, Abraham E. In: Holland SM Ed, Cytokine Therapeutics in Infectious Diseases. Philadelphia, Lippincott Williams and Wilkins 2001; pp 1-14.
220. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Ann Intern Med 1966; 64: 328-340.
221. Jendiroba DB, Freireich EJ. Blood Rev 2000; 14: 219-227.
222. Strauss RG. J Clin Apheresis 1995: 10: 114-118.
223. Bhatia S, McCullough J, Perry EH, Clay M, Ramsay NKC, Neglia JP. Transfusion 1994; 34: 226-232.
224. Samadi DS, Goldberg AN, Orlandi RR. Am J Rhinol 2001; 15: 4: 263-265.
225. Bradley TR, Metcalf D. Aust J Exp Biol Med Sci 1966; 44: 287-300.
226. Metcalf D. Cancer 1990; 65: 2185-2194.
227. Rubenstein EB. Int J Antimicrob Agents 2000; 16: 117-121.
228. Sereti I, Lane HC. Clin Infect Dis 2001; 32: 1738-1755.
229. Hartung T, Pitrak DL, Foote M, Shatzen EM, Verral SC, Wendel A. J Infect Dis 1998; 178: 686-692.
230. Lafeuillade A, Poggi C, Tamalet C. Lancet 1996; 347: 1123-1124.
231. Kandanearatchi A, Zuckerman M, Smith M, Vyakarnam A, Everall IP. AIDS 2002; 16: 413-420.
232. Lieschke GJ, Burgess AW. New Engl J Med 1992; 327: 99-106.
233. Perno CF, Cooney DA, Gao WY, Hao Z, Johns DG, Foli A, et al. Blood 1992; 80: 995-1003.
234. Nelson S. Chest 2001; 119 (Suppl 2): S419-S425.
235. Ellis M, Watson R, McNabb A, Lukic ML, Norks M. J Med Microbiol 2002; 51: 70-75.
236. RK, Dale DC. J Infect Dis 1999; 179 (Suppl 2): S342-S352.
237. Hartung T, Von Aulock S, Wendel A. Med Microbiol Immunol 1998; 187: 61-69.
238. Young AS, Cummins JM. East Afr Med J 1990; 67 (Suppl 2): S31-S63.
239. Isaacs A, Lindenmann J. Proc R Soc Lond (Biol) 1957; 147: 149-161.
240. Cantell K. Ann Med 1995; 27: 23-28.
241. Minkovitz JB, Pepose JS. Cornea 1995; 14: 326-330.
242. Malik AH, Lee WM. Ann Intern Med 2000; 132: 723-731.
243. Chisari FV, Ferrari C. Annu Rev Immunol 1995; 13: 29-60.
244. Woo MH, Burnakis TG. Ann Pharmacother 1997; 31: 330-337.
245. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, et al. N Engl J Med 1986; 315: 1575-1578.
246. Fontaine H, Chaix ML, Lagneau J L, Brechot C, Pol S. Lancet 2000; 356: 41.
247. Zeuzem S, Feinman SV, Rasenack J, Heathcote J, Lai MY, Gane E, et al. New Engl J Med 2000; 343: 1666-1672.
248. Melian EB, Plosker GL. Drugs 2001; 61: 1661-1691.
249. Poynard T, Regimbeau C, Myers RP, Thevenot T, Leroy V, Mathurin P, et al. The Cochrane Library Issue 1: 2002; CD000369.
250. Rajan S, Liebman HA. Am J Hematol 2001; 68: 202-209.
251. Falck-Ytter Y, Kale H, Mullen KD, Steedman AS, Sorescu L, McCullough AJ. Ann Intern Med 2002; 136: 288-292.
252. Krown SE. Curr Opin Hematol 2001; 13: 374-381.
253. Murray HW. Intensive Care Med 1996; 22: S456-S461.
254. Van Dissel JT, Arend SM, Ottenhoff THM. Neth J Med 2001; 59: 90-94.
255. Gallin JI. Ann Intern Med 1995; 123: 216-224.
256. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med 1991; 324: 509-516.
257. Mulliez P, Jaggi F, Darras A, Demory JL, Smith M. Rev Mal Resp 2000; 17: 975-978.
258. Holland SM. Sem Resp Infect 2001; 16: 47-59.
259. Dumoulin FL, Leifeld L, Sauerbruch T, Spengler U. Biomed Pharmacother 1999; 53: 242-254.
260. De Paoli P. Clin Diag Lab Immunol 2001; 8: 671-677.
261. Kovacs JA, Imamichi H, Vogel S, Metcalf JA, Dewar RL, Baseler M, et al. J Infect Dis 2000; 182: 1063-1069.
262. Cooper DA, Emery S. Nat Med 1999; 5: 611-612.
263. Emery S, Capra WB, Cooper DA, Mitsuyasu RT, Kovacs JA, Vig P, et al. J Infect Dis 2000; 182: 428-434.
264. Schlaak JF, Schramm C, Radecke K, Meyer Zum Bueschenfelde K-H, Gerken G. J Acquir Immune Defic Syndr 2002; 29: 145-148.
265. Vial T, Descotes J. Toxicology 1995; 105: 31-57.
266. Toren A, Or R, Ackerstein A, Nagler A. Bone Marrow Transplant 1997; 20: 67-69.
267. Angel JB, Jacobsons MA, Skolnik PR, Giordano M, Shapiro L, LeBeaut A, et al. AIDS 2000; 14: 2503-2508.
268. McDyer JF, Wu CY, Kelsall BL, Seder RA. In: Holland SM Ed, Cytokine Therapeutics in Infectious Diseases. Philadelphia, Lippincott Williams and Wilkins 2001; pp 85-104.
269. Greinert U, Ernst M, Schlaak M, Entzian P. Eur Resp J 2001; 17: 1049-1051.
270. Gately MK. J Viral Hepat 1997; 4 (Suppl 1): 33-39.
271. Ancell CD, Phipps J, Young L. Am J Health Syst Pharm 2001; 58: 879-885.
272. Lau GK. J Gastroenterol Hepatol 2000; 15 (Suppl): E46-E52.
273. Tzianabos AO. Clin Micrrobiol Rev 2000; 13: 523-533.
274. Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, et al. Arch Surg 1999; 134: 977-983.
275. Gorden M, Deeks S, de Marzo C, Goodgame J, Guralnik M, Lang W, et al. J Med 1997; 28: 108-128.
276. Juffermans NP, Leemans JC, Florquin S, Verbon A, Kolk AH, Speelman P, et al. Infect Immun 2002; 70: 147-152.
277. Ritts RE. J Antimicrob Chemother 1990; 26 (Suppl C): 31-36.
278. Labro MT. Int J Antimicrob Agents 1998; 10: 11-21.
279. Nosanchuk JD, Casadevall A. Recent Res Devel Antimicrob Agents & Chemother 1999; 3: 7-15.
280. Barrett JF. Exp Opin Invest Drugs 1995; 4: 551-557.
281. Gemmell CG. J Antimicrob Chemother 1993; 31 (Suppl B): 23-33.
282. Williams JD. Int J Antimicrob Agents 2001; 18 (Suppl 1): S89-S91.
283. Trostdorf F, Reinert RR, Schmidt H, Nichterlein T, Stuertz K, Schmitz-Salue M, et al. J Antimicrob Chemother 1999; 43: 87-94.
284. Duong M, Simard M, Bergeron Y, Bergeron MG. Antimicrob Agents Chemother 2001; 45: 252-262.
285. Labro MT. J Antimicrob Chemother 1990; 26 (Suppl C): 37-47.
286. Frank MO, Mandell GL. In: Mandell GL, Bennett JE, Dolin R Eds, Mandell Douglas and Bennett's Principles and Practice of Infectious Diseases 4th edition. New York, Churchill Livingston 1995; pp 450-458.
287. Saez-Llorens X, McCracken GH, Jr. Infect Dis Clin North Am 1999; 13: 619-639.
288. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G. J Exp Med 1991; 173: 699-703.
289. Dezube BJ, Lederman MM, Spritzler JG, Chapman B, Korvick JA, Flexner C, et al. J Infect Dis 1995; 171: 1628-1632.
290. Holland S. Sem Resp Infect 2001; 16: 47-59.
291. Jansen WTM, Breukels MA, Snippe H, Sanders LAM, Verheul AFM, Rijkers GT. J Infect Dis 1999; 180: 888-891.
292. Zhong Z, Burns T, Chang Q, Carroll M, Pirofski L. Infect Immun 1999; 4119-4127.
293. Han Y, Kozel TR, Zhang MX, MacGill RS, Carroll MC, Cutler JE. J Immunol 2001; 167: 1550-1557.
294. Fleuridor R, Zhong Z, Pirofski L. J Infect Dis 1998; 178: 1213-1216.
295. Berger M, Norvell TM, Tosi MF, Emancipator SN, Konstan MW, Schreiber JR. Pediatr Res 1994; 35: 68-77.
296. Lee KH. Curr Pharm Des 2002; 8(9): 795-813.
297. Milenic DE. Curr Pharm Des 2002; 8(19): 1749-64.
298. Schein CH. Curr Pharm Des. 2002; 8(24), 2113-29.